7LBA A 4 gene model can identify ER+HER2+ breast cancers unlikely to respond to neoadjuvant endocrine therapy
Turnbull, A.K, Webber, V, Arthur, L.M, Larionov, A.A, Renshaw, L, Kay, C, Sims, A.H, Dixon, J.M
Published in European journal of cancer (1990) (01.03.2014)
Published in European journal of cancer (1990) (01.03.2014)
Get full text
Journal Article
284P - Changes in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients
Turnbull, A.K., Inda, M.A., van de Stolpe, A., Keizer, D., Clout, D., van Zon, H., Akse, M., Fernando, A., Martinez-Perez, C., Dixon, J.M., Sims, A.H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Changes in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients
Turnbull, A.K., Inda, M.A., van de Stolpe, A., Keizer, D., Clout, D., van Zon, H., Akse, M., Fernando, A., Martinez-Perez, C., Dixon, J.M., Sims, A.H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy
Keizer, D., Inda, M.A., Clout, D., van de Stolpe, A., Fernando, A., Martinez-Perez, C., Dixon, J.M., Sims, A.H., Turnbull, A.K.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer
Arthur, L. M., Turnbull, A. K., Renshaw, L., Keys, J., Thomas, J. S., Wilson, T. R., Lackner, M. R., Sims, A. H., Dixon, J. M.
Published in Breast cancer research and treatment (01.08.2014)
Published in Breast cancer research and treatment (01.08.2014)
Get full text
Journal Article